Cargando…

Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbidities

Alzheimer’s disease is a multifactorial disorder with large heterogeneity. Comorbidities such as hypertension, hypercholesterolaemia and diabetes are known contributors to disease progression. However, less is known about their mechanistic contribution to Alzheimer’s pathology and neurodegeneration....

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniilidou, Makrina, Eroli, Francesca, Alanko, Vilma, Goikolea, Julen, Latorre-Leal, Maria, Rodriguez-Rodriguez, Patricia, Griffiths, William J, Wang, Yuqin, Pacciarini, Manuela, Brinkmalm, Ann, Zetterberg, Henrik, Blennow, Kaj, Rosenberg, Anna, Bogdanovic, Nenad, Winblad, Bengt, Kivipelto, Miia, Ibghi, Delphine, Cedazo-Minguez, Angel, Maioli, Silvia, Matton, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481253/ https://www.ncbi.nlm.nih.gov/pubmed/37680670 http://dx.doi.org/10.1093/braincomms/fcad228

Ejemplares similares

Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD
por: Goikolea, Julen, et al.
Publicado: (2022)

27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)

Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice
por: Francesca, Eroli, et al.
Publicado: (2021)

Ketosis After Intake of Coconut Oil and Caprylic Acid—With and Without Glucose: A Cross-Over Study in Healthy Older Adults
por: Norgren, Jakob, et al.
Publicado: (2020)

Serum proBDNF Is Associated With Changes in the Ketone Body β-Hydroxybutyrate and Shows Superior Repeatability Over Mature BDNF: Secondary Outcomes From a Cross-Over Trial in Healthy Older Adults
por: Norgren, Jakob, et al.
Publicado: (2021)

Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult mice
por: Eroli, Francesca, et al.
Publicado: (2020)

Reduction of PINK1 or DJ‐1 impair mitochondrial motility in neurites and alter ER‐mitochondria contacts
por: Parrado‐Fernández, Cristina, et al.
Publicado: (2018)

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic
por: Bucci, Marco, et al.
Publicado: (2023)

Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study
por: Kivipelto, Miia, et al.
Publicado: (2008)

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
por: Sjödin, Simon, et al.
Publicado: (2016)

Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis
por: Persson, Torbjörn, et al.
Publicado: (2017)

Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and Neurodegeneration
por: Loera-Valencia, Raúl, et al.
Publicado: (2021)

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
por: Sjödin, Simon, et al.
Publicado: (2017)

Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
por: Parrado‐Fernández, Cristina, et al.
Publicado: (2018)

Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
por: Rosenberg, Anna, et al.
Publicado: (2021)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
por: Minta, Karolina, et al.
Publicado: (2021)

The Dietary Carbohydrate/Fat-Ratio and Cognitive Performance: Panel Analyses in Older Adults at Risk for Dementia
por: Norgren, Jakob, et al.
Publicado: (2023)

Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study
por: Håkansson, Krister, et al.
Publicado: (2015)

Correction: Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study
por: Håkansson, Krister, et al.
Publicado: (2015)

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
por: Sjödin, Simon, et al.
Publicado: (2019)

The composition of polypharmacy: A register-based study of Swedes aged 75 years and older
por: Wastesson, Jonas W., et al.
Publicado: (2018)

Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL
por: Panahi, Mahmod, et al.
Publicado: (2020)

Fluid Biomarkers for Synaptic Dysfunction and Loss
por: Camporesi, Elena, et al.
Publicado: (2020)

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
por: Öhrfelt, Annika, et al.
Publicado: (2016)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
por: Duits, Flora H., et al.
Publicado: (2018)

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
por: Rosenberg, Anna, et al.
Publicado: (2019)

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry
por: Camporesi, Elena, et al.
Publicado: (2022)

Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)

Sex difference in flux of 27‐hydroxycholesterol into the brain
por: Parrado‐Fernandez, Cristina, et al.
Publicado: (2021)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
por: Brinkmalm, Ann, et al.
Publicado: (2014)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
por: Soininen, Hilkka, et al.
Publicado: (2017)

36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease
por: Soininen, Hilkka, et al.
Publicado: (2020)

Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
por: Gil-Bea, Francisco, et al.
Publicado: (2012)

Brain Renin–Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer’s Disease
por: Loera-Valencia, Raúl, et al.
Publicado: (2021)

Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities
por: Cedazo-Mínguez, Angel
Publicado: (2007)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

SR Protein Kinase 1 Inhibition by TAF15
por: Koukiali, Anastasia, et al.
Publicado: (2022)

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
por: Kvartsberg, Hlin, et al.
Publicado: (2018)

Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2dc15ee0kas3o070l29k90sln